FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912704270> ?p ?o ?g. }

• W2912704270 endingPage "81" @default.
• W2912704270 startingPage "72" @default.
• W2912704270 abstract "We previously reported that hydrangenol has potent antitumor activity against human bladder cancer EJ cells. Here, we investigated the antiangiogenic activity of hydrangenol using in vitro and ex vivo models. Treatment with hydrangenol significantly inhibited the proliferation of vascular endothelial growth factor (VEGF)-induced HUVECs in a concentration-dependent manner (EC50 = 10 μM). Flow cytometry analysis revealed that hydrangenol suppressed the VEGF-induced inhibition of G1-cell cycle phase and also decreased cyclin D1, cyclin E, CDK2, and CDK4 levels. Hydrangenol-mediated arrest in the G1-cell cycle phase was associated with p27KIP1 level, but not p21WAF1 or p53 level. Hydrangenol also significantly inhibited VEGFR-2-mediated signaling pathways including ERK1/2, AKT, and endothelial nitric oxide synthase. Interestingly, immunoprecipitation assay demonstrated that the inhibition of VEGFR-2 activation was independent of VEGF binding, thereby suggesting an allosteric regulation of hydrangenol against VEGFR-2. Additionally, hydrangenol inhibited migration, invasion, and capillary-like tubular formation in VEGF-stimulated HUVECs. Zymography and immunoblot analyses revealed that these inhibitory activities were partially owing to the VEGF-induced inhibition of matrix metalloproteinase-2 activity. Finally, VEGF-mediated microvessel sprouting was inhibited in the presence of hydrangenol in ex vivo aortic ring assay. Taken together, hydrangenol possesses a potent antiangiogenesis potential; thus we believe that hydrangenol may be developed as a therapeutic reagent to treat angiogenesis-mediated diseases." @default.
• W2912704270 created "2019-02-21" @default.
• W2912704270 creator A5028262111 @default.
• W2912704270 creator A5038033108 @default.
• W2912704270 creator A5043707908 @default.
• W2912704270 creator A5060648265 @default.
• W2912704270 creator A5080001926 @default.
• W2912704270 creator A5091843504 @default.
• W2912704270 date "2019-02-14" @default.
• W2912704270 modified "2023-09-24" @default.
• W2912704270 title "Hydrangenol suppresses VEGF-stimulated angiogenesis by targeting p27KIP1-dependent G1-cell cycle arrest, VEGFR-2-mediated signaling, and MMP-2 expression" @default.
• W2912704270 cites W1573363574 @default.
• W2912704270 cites W1607892649 @default.
• W2912704270 cites W1657618026 @default.
• W2912704270 cites W1783580437 @default.
• W2912704270 cites W1824182589 @default.
• W2912704270 cites W19410018 @default.
• W2912704270 cites W1969248212 @default.
• W2912704270 cites W1978139448 @default.
• W2912704270 cites W1981431966 @default.
• W2912704270 cites W1994360534 @default.
• W2912704270 cites W2031366392 @default.
• W2912704270 cites W2032017022 @default.
• W2912704270 cites W2049693200 @default.
• W2912704270 cites W2050555289 @default.
• W2912704270 cites W2054728198 @default.
• W2912704270 cites W2065550467 @default.
• W2912704270 cites W2156713309 @default.
• W2912704270 cites W2285730654 @default.
• W2912704270 cites W2320751016 @default.
• W2912704270 cites W2415956546 @default.
• W2912704270 cites W2945373284 @default.
• W2912704270 doi "https://doi.org/10.1080/19768354.2019.1578262" @default.
• W2912704270 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6440517" @default.
• W2912704270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30949393" @default.
• W2912704270 hasPublicationYear "2019" @default.
• W2912704270 type Work @default.
• W2912704270 sameAs 2912704270 @default.
• W2912704270 citedByCount "13" @default.
• W2912704270 countsByYear W29127042702019 @default.
• W2912704270 countsByYear W29127042702020 @default.
• W2912704270 countsByYear W29127042702021 @default.
• W2912704270 countsByYear W29127042702022 @default.
• W2912704270 countsByYear W29127042702023 @default.
• W2912704270 crossrefType "journal-article" @default.
• W2912704270 hasAuthorship W2912704270A5028262111 @default.
• W2912704270 hasAuthorship W2912704270A5038033108 @default.
• W2912704270 hasAuthorship W2912704270A5043707908 @default.
• W2912704270 hasAuthorship W2912704270A5060648265 @default.
• W2912704270 hasAuthorship W2912704270A5080001926 @default.
• W2912704270 hasAuthorship W2912704270A5091843504 @default.
• W2912704270 hasBestOaLocation W29127042701 @default.
• W2912704270 hasConcept C109523444 @default.
• W2912704270 hasConcept C1491633281 @default.
• W2912704270 hasConcept C16438837 @default.
• W2912704270 hasConcept C167734588 @default.
• W2912704270 hasConcept C185592680 @default.
• W2912704270 hasConcept C199835354 @default.
• W2912704270 hasConcept C2777025900 @default.
• W2912704270 hasConcept C2780394083 @default.
• W2912704270 hasConcept C29537977 @default.
• W2912704270 hasConcept C502942594 @default.
• W2912704270 hasConcept C55493867 @default.
• W2912704270 hasConcept C62478195 @default.
• W2912704270 hasConcept C75217442 @default.
• W2912704270 hasConcept C86803240 @default.
• W2912704270 hasConcept C95444343 @default.
• W2912704270 hasConceptScore W2912704270C109523444 @default.
• W2912704270 hasConceptScore W2912704270C1491633281 @default.
• W2912704270 hasConceptScore W2912704270C16438837 @default.
• W2912704270 hasConceptScore W2912704270C167734588 @default.
• W2912704270 hasConceptScore W2912704270C185592680 @default.
• W2912704270 hasConceptScore W2912704270C199835354 @default.
• W2912704270 hasConceptScore W2912704270C2777025900 @default.
• W2912704270 hasConceptScore W2912704270C2780394083 @default.
• W2912704270 hasConceptScore W2912704270C29537977 @default.
• W2912704270 hasConceptScore W2912704270C502942594 @default.
• W2912704270 hasConceptScore W2912704270C55493867 @default.
• W2912704270 hasConceptScore W2912704270C62478195 @default.
• W2912704270 hasConceptScore W2912704270C75217442 @default.
• W2912704270 hasConceptScore W2912704270C86803240 @default.
• W2912704270 hasConceptScore W2912704270C95444343 @default.
• W2912704270 hasFunder F4320322120 @default.
• W2912704270 hasIssue "2" @default.
• W2912704270 hasLocation W29127042701 @default.
• W2912704270 hasLocation W29127042702 @default.
• W2912704270 hasLocation W29127042703 @default.
• W2912704270 hasLocation W29127042704 @default.
• W2912704270 hasLocation W29127042705 @default.
• W2912704270 hasOpenAccess W2912704270 @default.
• W2912704270 hasPrimaryLocation W29127042701 @default.
• W2912704270 hasRelatedWork W1969527608 @default.
• W2912704270 hasRelatedWork W1972308562 @default.
• W2912704270 hasRelatedWork W2012298156 @default.
• W2912704270 hasRelatedWork W2080152105 @default.
• W2912704270 hasRelatedWork W2091139028 @default.
• W2912704270 hasRelatedWork W2101492103 @default.
• W2912704270 hasRelatedWork W2315114303 @default.

• next